New Zealand Health Technology Assessment (NZHTA) THE CLEARING HOUSE FOR HEALTH OUTCOMES AND HEALTH TECHNOLOGY ASSESSMENT

THE CLEARING HOUSE FOR HEALTH OUTCOMES AND HEALTH TECHNOLOGY ASSESSMENT Department of Public Health and General Practice Christchurch School of Medicine Rehabilitation of cerebrovascular disorder (stroke): early discharge and support A critical appraisal of the literature

Involvement of Patients in Health Technology Assessment: Further Perspectives for Informing Decision-Makers

Health technology assessment (HTA) is an evaluative process used to inform technology-related policymaking in healthcare. Interest in involving patients in the HTA process is increasing. Patients can provide additional perspectives to those of other groups that are concerned with health technology. Information on patients’ perspectives is preferably obtained through reviews of published studies...

Health technology assessment on super oxidized water for treatment of chronic wounds

Background: Super oxidized water (SOW), as a novel antiseptic solution, is used with claims of effectiveness and cost effectiveness in healing chronic wounds such as diabetic foot, infectious post-operative ulcers and burn ulcers. We conducted a health technology assessment to evaluate the clinical evidence from clinical and randomized trials for this disinfection. This study aims to evaluate t...

Health Technology Assessment of the Psychotherapy Effect on Prevention of Suicide and Self-Harm: A Rapid Review of Secondary Studies

Introduction: According to the World Health Organization (WHO) report, acute depression disorders are the second largest health problem in the world which can cause disability and imposes huge costs on individuals and societies. This study aims to investigate the effectiveness and cost-effectiveness of using psychotherapy in patients with depression for prevention of suicide an...

Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.

BACKGROUND Personalized medicine technologies can improve individual health by delivering the right dose of the right drug to the right patient at the right time but create challenges in deciding which technologies offer sufficient value to justify widespread diffusion. Personalized medicine technologies, however, do not neatly fit into existing health technology assessment and reimbursement pr...